Tumor vasculature remodeling by radiation therapy increases doxorubicin distribution and efficacy.


Journal

Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053

Informations de publication

Date de publication:
10 08 2019
Historique:
received: 20 09 2018
revised: 30 04 2019
accepted: 06 05 2019
pubmed: 13 5 2019
medline: 28 4 2020
entrez: 13 5 2019
Statut: ppublish

Résumé

The tumor microenvironment regulates cancer initiation, progression and response to treatment. In particular, the immature tumor vasculature may impede drugs from reaching tumor cells at a lethal concentration. We and others have shown that radiation therapy (RT) induces pericyte recruitment, resembling vascular normalization. Here, we asked whether radiation-induced vascular remodeling translates into improved tissue distribution and efficacy of chemotherapy. First, RT induced vascular remodeling, accompanied by decreased hypoxia and/or increased Hoechst perfusion in prostate PC3 and LNCaP and Lewis lung carcinoma. These results were independent of the RT regimen, respectively 10 × 2 Gy and 2 × 12 Gy, suggesting a common effect. Next, using doxorubicin as a fluorescent reporter, we observed that RT improves intra-tumoral chemotherapy distribution. These effects were not hindered by anti-angiogenic sunitinib. Moreover, sub-optimal doses of doxorubicin had almost no effect alone, but significantly delayed tumor growth after RT. These data demonstrate that RT favors the efficacy of chemotherapy by improving tissue distribution, and could be an alternative chemosensitizing strategy.

Identifiants

pubmed: 31078733
pii: S0304-3835(19)30281-2
doi: 10.1016/j.canlet.2019.05.005
pii:
doi:

Substances chimiques

Antibiotics, Antineoplastic 0
Doxorubicin 80168379AG

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-9

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Vincent Potiron (V)

CRCINA, INSERM, Université de Nantes, Université D'Angers, Nantes, France; Institut de Cancérologie de L'Ouest René Gauducheau, Saint-Herblain, France.

Karen Clément-Colmou (K)

CRCINA, INSERM, Université de Nantes, Université D'Angers, Nantes, France; Institut de Cancérologie de L'Ouest René Gauducheau, Saint-Herblain, France.

Emmanuel Jouglar (E)

CRCINA, INSERM, Université de Nantes, Université D'Angers, Nantes, France; Institut de Cancérologie de L'Ouest René Gauducheau, Saint-Herblain, France.

Manon Pietri (M)

CRCINA, INSERM, Université de Nantes, Université D'Angers, Nantes, France; Institut de Cancérologie de L'Ouest René Gauducheau, Saint-Herblain, France.

Sophie Chiavassa (S)

CRCINA, INSERM, Université de Nantes, Université D'Angers, Nantes, France; Institut de Cancérologie de L'Ouest René Gauducheau, Saint-Herblain, France.

Grégory Delpon (G)

CRCINA, INSERM, Université de Nantes, Université D'Angers, Nantes, France; Institut de Cancérologie de L'Ouest René Gauducheau, Saint-Herblain, France.

François Paris (F)

CRCINA, INSERM, Université de Nantes, Université D'Angers, Nantes, France; Institut de Cancérologie de L'Ouest René Gauducheau, Saint-Herblain, France.

Stéphane Supiot (S)

CRCINA, INSERM, Université de Nantes, Université D'Angers, Nantes, France; Institut de Cancérologie de L'Ouest René Gauducheau, Saint-Herblain, France. Electronic address: stephane.supiot@ico.unicancer.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH